Context Therapeutics (CNTX) Revenue & Revenue Breakdown
Context Therapeutics Revenue Highlights
00
Context Therapeutics Revenue by Period
Context Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Context Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $18.95K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Context Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
CHRS | Coherus BioSciences | $257.24M | $70.77M |
WVE | Wave Life Sciences | $113.31M | $19.69M |
CTMX | CytomX Therapeutics | $101.21M | $33.43M |
SPRO | Spero Therapeutics | $96.73M | $13.47M |
BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
CNTX | Context Therapeutics | - | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ZURA | Zura Bio | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
NXTC | NextCure | - | - |
INAB | IN8bio | - | - |
ANNX | Annexon | - | - |
TERN | Terns Pharmaceuticals | - | - |